2021
Oswald LB, Victorson DE, Fox RS. 2021. Young adult cancer survivors’ preferences for supportive interventions. Psychooncology. 30:982–985. doi:10.1002/pon.5664.
2020
Fu Z, Tseng HW, Vedantham S, Karellas A, Bilgin A. 2020. A residual dense network assisted sparse view reconstruction for breast computed tomography. Scientific Reports. 10(1). doi:10.1038/s41598-020-77923-0.
Chalasani P, Taljanovic M, Segar J, Farr K, Win H, Wertheim BC, Chu-Pilli M, Ehsani S, Roe DJ, Gimber L. 2020. Diffuse tensor imaging of lower extremities: a novel MR imaging technique for chemotherapy-induced peripheral neuropathy. Breast Cancer Res Treat. 184:771–778. doi:10.1007/s10549-020-05897-8.
Holokai L, Chakrabarti J, Lundy J, Croagh D, Adhikary P, Richards SS, Woodson C, Steele N, Kuester R, Scott A, et al. 2020. Murine- and Human-Derived Autologous Organoid/Immune Cell Co-Cultures as Pre-Clinical Models of Pancreatic Ductal Adenocarcinoma. Cancers (Basel). 12. doi:10.3390/cancers12123816.
Jain J, Weinzierl EP, Saxe D, Bergsagel J, Gotlib J, Reiter A, Raikar SS. 2020. Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase -Associated Myeloid Neoplasm With Eosinophilia. Hemasphere. 4:e486. doi:10.1097/HS9.0000000000000486.
Kobayashi S, Thelin MA, Parrish HL, Deshpande NR, Lee MS, Karimzadeh A, Niewczas MA, Serwold T, Kuhns MS. 2020. A biomimetic five-module chimeric antigen receptor (CAR) designed to target and eliminate antigen-specific T cells. Proc Natl Acad Sci U S A. 117:28950–28959. doi:10.1073/pnas.2012495117.
Fu Z, Mandava S, Keerthivasan MB, Li Z, Johnson K, Martin DR, Altbach MI, Bilgin A. 2020. A multi-scale residual network for accelerated radial MR parameter mapping. Magn Reson Imaging. 73:152–162. doi:10.1016/j.mri.2020.08.013.
Melson JE, Imperiale TF, Itzkowitz SH, Llor X, Kochman ML, Grady WM, Schoen RE, Burke CA, Shaukat A, Rabeneck L, et al. 2020. AGA White Paper: Roadmap for the Future of Colorectal Cancer Screening in the United States. Clin Gastroenterol Hepatol. 18:2667–2678.e2. doi:10.1016/j.cgh.2020.06.053.
Bowen C, Shibata M, Zhang H, Bergren SK, Shen MM, Gelmann EP. 2020. CRISPR/Cas9-Mediated Point Mutation in Prolongs Protein Half-Life and Reverses Effects Allelic Loss. Cancer Res. 80:4805–4814. doi:10.1158/0008-5472.CAN-20-1742.
Martin L, Porreca F, Mata EI, Salloum M, Goel V, Gunnala P, Killgore WDS, Jain S, Jones-MacFarland FN, Khanna R, et al. 2020 Nov. Green Light Exposure Improves Pain and Quality of Life in Fibromyalgia Patients: A Preliminary One-Way Crossover Clinical Trial. Pain Med. doi:10.1093/pm/pnaa329.
Sun BL, Sun X, Casanova N, Garcia AN, Oita R, Algotar AM, Camp SM, Hernon VR, Gregory T, Cress AE, et al. 2020. Role of secreted extracellular nicotinamide phosphoribosyltransferase (eNAMPT) in prostate cancer progression: Novel biomarker and therapeutic target. EBioMedicine. 61:103059. doi:10.1016/j.ebiom.2020.103059.
Iesa MAM, Osman MEM, Hassan MA, Dirar AIA, Abuzeid N, Mancuso JJ, Pandey R, Mohammed AA, Borad MJ, Babiker HM, et al. 2020. SARS-CoV-2 and common immunodominant regions may explain low COVID-19 incidence in the malaria-endemic belt. New Microbes New Infect. 38:100817. doi:10.1016/j.nmni.2020.100817.
Alkhatib NS, Abraham I. 2020. The six Delta platform for outcome-based contracting for pharmaceuticals. J Med Econ. 23:1209–1214. doi:10.1080/13696998.2020.1824161.
Arshad J, Roberts A, Ahmed J, Cotta J, Pico BA, Kwon D, Trent JC. 2020. Utility of Circulating Tumor DNA in the Management of Patients With GI Stromal Tumor: Analysis of 243 Patients. JCO Precision Oncology.(4):66–73. doi:10.1200/po.19.00253.
Wren SN, Donovan MG, Selmin OI, Doetschman TC, Romagnolo DF. 2020. A -Driven Transgene Modulates Enterohepatic Bile Acid Homeostasis and Response to an -6-Enriched High-Fat Diet. Int J Mol Sci. 21. doi:10.3390/ijms21217829.
Zhang J, Sun Y, Chen J, Yang D, Liang R. 2020. Deep-learning-based hyperspectral recovery from a single RGB image. Opt Lett. 45:5676–5679. doi:10.1364/OL.405061.
Batai K, Sanderson PR, Hsu C-H, Joshweseoma L, Russell D, Joshweseoma L, Ojeda J, Burhansstipanov L, Brown SR, Ami D, et al. 2020 Oct. Factors Associated with Cancer Screening Among Hopi Men. J Cancer Educ. doi:10.1007/s13187-020-01900-4.
Jamwal DR, Laubitz D, Harrison CA, Figliuolo da Paz V, Cox CM, Wong R, Midura-Kiela M, Gurney MA, Besselsen DG, Setty P, et al. 2020. Intestinal Epithelial Expression of MHCII Determines Severity of Chemical, T-Cell-Induced, and Infectious Colitis in Mice. Gastroenterology. 159:1342–1356.e6. doi:10.1053/j.gastro.2020.06.049.
Wang C, Wang X, Zhang L, Yue Q, Liu Q, Xu Y-M, Gunatilaka AAL, Wei X, Xu Y, Molnár I. 2020. Intrinsic and Extrinsic Programming of Product Chain Length and Release Mode in Fungal Collaborating Iterative Polyketide Synthases. J Am Chem Soc. 142:17093–17104. doi:10.1021/jacs.0c07050.
Dudek AZ, Liu LC, Fischer JH, Wiley EL, Sachdev JC, Bleeker J, Hurley RW, Tonetti DA, Thatcher GRJ, Venuti RP, et al. 2020. Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy. Breast Cancer Res Treat. 183:617–627. doi:10.1007/s10549-020-05787-z.
Smith SF, Collins SE, Charest PG. 2020. Ras, PI3K and mTORC2 - three’s a crowd?. J Cell Sci. 133. doi:10.1242/jcs.234930.
Penedo FJ, Fox RS, Oswald LB, Moreno PI, Boland CL, Estabrook R, McGinty HL, Mohr DC, Begale MJ, Dahn JR, et al. 2020. Technology-Based Psychosocial Intervention to Improve Quality of Life and Reduce Symptom Burden in Men with Advanced Prostate Cancer: Results from a Randomized Controlled Trial. Int J Behav Med. 27:490–505. doi:10.1007/s12529-019-09839-7.
Trejo MJ, Bell ML, Dhillon HM, Vardy JL. 2020. Baseline quality of life is associated with survival among people with advanced lung cancer. J Psychosoc Oncol. 38:635–641. doi:10.1080/07347332.2020.1765065.
Florea A, Harris RB, Klimentidis YC, Kohler LN, Jurutka PW, Jacobs ET. 2020 Sep. Circulating Fibroblast Growth Factor-21 and Risk of Metachronous Colorectal Adenoma. J Gastrointest Cancer. doi:10.1007/s12029-020-00515-8.
Crane TE, Skiba MB, Miller A, Garcia DO, Thomson CA. 2020. Development and Evaluation of an Accelerometer-Based Protocol for Measuring Physical Activity Levels in Cancer Survivors: Development and Usability Study. JMIR Mhealth Uhealth. 8:e18491. doi:10.2196/18491.
Pagination
- First page
- …
- 7
- 8
- 9
- …
- Last page